Metabolon Blog


Metabolon: The Leader in Metabolomics

About UsMetabolon is a pioneer and leader in metabolomics - an integrative, powerful phenotyping technology for assessing health. Its proprietary platforms and informatics systems are delivering biomarker discoveries, innovative diagnostic tests, breakthroughs in precision medicine, and robust partnerships in genomics-based health initiatives.

We offer scalable, customizable research services to academic and commercial investigators in every area of the life sciences. We are also using our technology to advance precision medicine and develop novel metabolomics-based clinical diagnostic tests that may improve early detection of diseases.

Innovation Powered by Proprietary Technology

Our experienced team of Ph.D. scientists, biostatisticians and informaticists has created the industry’s most comprehensive metabolomics platform (DiscoveryHD4™). We also offer a suite of focused panels and customizable targeted assays, which are useful for validating hypotheses or exploring a particular metabolite or metabolite class. 

Metabolon has developed novel clinical diagnostic tests derived from our metabolomics expertise. Our laboratory-developed tests (LDTs) include Quantose IR™ (a blood test for gauging early-stage insulin resistance) and Quantose IGT™ (a blood test that measures impaired glucose tolerance). Quantose IR was the first metabolomics-based LDT on the market and is currently available in the U.S., Mexico and Europe. Quantose IGT is available as an LDT in the U.S. Our growing diagnostics pipeline is focused on obesity-related diseases.

Unmatched Experience & Expertise

Since its founding in 2000, Metabolon has served nearly 700 clients from both industry and academia, and we have formed strategic partnerships with several major research institutions, as well as many pharmaceutical, agricultural, bioprocessing and consumer goods companies.

We currently have over 160 highly qualified employees, including more than 40 Ph.D.s from diverse backgrounds in molecular biology and biochemistry, and an experienced staff of statisticians, bioinformaticians, chemists, software developers and engineers. With more than 4,000 completed projects behind us, our institutional knowledge is unmatched in the industry.

In addition, the staff at Metabolon has written and contributed to nearly 500 peer-reviewed journal publications, including numerous articles in Cell, Nature and Science. Our publications and studies can be reviewed in the Resources section of this website.